Literature DB >> 22098667

Effect of bile duct ligation on bile acid composition in mouse serum and liver.

Youcai Zhang1, Ji-Young Hong, Cheryl E Rockwell, Bryan L Copple, Hartmut Jaeschke, Curtis D Klaassen.   

Abstract

BACKGROUND: Cholestatic liver diseases can be caused by genetic defects, drug toxicities, hepatobiliary malignancies or obstruction of the biliary tract. Cholestasis leads to accumulation of bile acids (BAs) in hepatocytes. Direct toxicity of BAs is currently the most accepted hypothesis for cholestatic liver injury. However, information on which bile acids are actually accumulating during cholestasis is limited. AIM: To assess the BA composition in liver and serum after bile duct ligation (BDL) in male C57Bl/6 mice between 6 h and 14 days and evaluate toxicity of the most abundant BAs.
RESULTS: Bile acid concentrations increased in liver (27-fold) and serum (1400-fold) within 6 h after surgery and remained elevated up to 14 days. BAs in livers of BDL mice became more hydrophilic than sham controls, mainly because of increased 6β-hydroxylation and taurine conjugation. Among the eight unconjugated and 16 conjugated BAs identified in serum and liver, only taurocholic acid (TCA), β-muricholic acid (βMCA) and TβMCA were substantially elevated representing >95% of these BAs over the entire time course. Although glycochenodeoxycholic acid and other conjugated BAs increased in BDL animals, the changes were several orders of magnitude lower compared with TCA, βMCA and TβMCA. A mixture of these BAs did not cause apoptosis or necrosis, but induced inflammatory gene expression in cultured murine hepatocytes.
CONCLUSION: The concentrations of cytotoxic BAs are insufficient to cause hepatocellular injury. In contrast, TCA, βMCA and TβMCA are able to induce pro-inflammatory mediators in hepatocytes. Thus, BAs act as inflammagens and not as cytotoxic mediators after BDL in mice.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22098667      PMCID: PMC3263524          DOI: 10.1111/j.1478-3231.2011.02662.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  49 in total

1.  Oncosis represents the main type of cell death in mouse models of cholestasis.

Authors:  Peter Fickert; Michael Trauner; Andrea Fuchsbichler; Gernot Zollner; Martin Wagner; Hanns-Ulrich Marschall; Kurt Zatloukal; Helmut Denk
Journal:  J Hepatol       Date:  2005-03       Impact factor: 25.083

2.  Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS.

Authors:  Yazen Alnouti; Iván L Csanaky; Curtis D Klaassen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-09-03       Impact factor: 3.205

3.  Early growth response factor-1 is critical for cholestatic liver injury.

Authors:  Nam Deuk Kim; Jeon-Ok Moon; Angela L Slitt; Bryan L Copple
Journal:  Toxicol Sci       Date:  2006-01-19       Impact factor: 4.849

4.  Bile salts induce resistance to apoptosis through NF-kappaB-mediated XIAP expression.

Authors:  Douglas J Turner; Samuel M Alaish; Tongtong Zou; Jaladanki N Rao; Jian-Ying Wang; Eric D Strauch
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

Review 5.  Coordinate regulation of hepatic bile acid oxidation and conjugation by nuclear receptors.

Authors:  Jocelyn Trottier; Piotr Milkiewicz; Jenny Kaeding; Mélanie Verreault; Olivier Barbier
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

Review 6.  Biliary secretion and excretion in health and disease: current concepts.

Authors:  Alan F Hofmann
Journal:  Ann Hepatol       Date:  2007 Jan-Mar       Impact factor: 2.400

7.  Hepatobiliary transporter expression in intercellular adhesion molecule 1 knockout and Fas receptor-deficient mice after common bile duct ligation is independent of the degree of inflammation and oxidative stress.

Authors:  Martin Wagner; Gernot Zollner; Peter Fickert; Judith Gumhold; Dagmar Silbert; Andrea Fuchsbichler; Jaspreet S Gujral; Kurt Zatloukal; Helmut Denk; Hartmut Jaeschke; Michael Trauner
Journal:  Drug Metab Dispos       Date:  2007-06-18       Impact factor: 3.922

8.  Chenodeoxycholic acid and taurochenodexycholic acid induce anti-apoptotic cIAP-1 expression in human hepatocytes.

Authors:  Fuminori Hirano; Masakazu Haneda; Isao Makino
Journal:  J Gastroenterol Hepatol       Date:  2006-12       Impact factor: 4.029

9.  Invariant natural killer T cells suppress the neutrophil inflammatory response in a mouse model of cholestatic liver damage.

Authors:  Philip Wintermeyer; Chao-Wen Cheng; Stephan Gehring; Beth L Hoffman; Martin Holub; Laurent Brossay; Stephen H Gregory
Journal:  Gastroenterology       Date:  2008-11-01       Impact factor: 22.682

10.  24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.

Authors:  Peter Fickert; Martin Wagner; Hanns-Ulrich Marschall; Andrea Fuchsbichler; Gernot Zollner; Oleksiy Tsybrovskyy; Kurt Zatloukal; Jie Liu; Michael P Waalkes; Cathleen Cover; Helmut Denk; Alan F Hofmann; Hartmut Jaeschke; Michael Trauner
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

View more
  74 in total

1.  Critical Factors in the Assessment of Cholestatic Liver Injury In Vitro.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Methods Mol Biol       Date:  2015

2.  Effect of various antibiotics on modulation of intestinal microbiota and bile acid profile in mice.

Authors:  Youcai Zhang; Pallavi B Limaye; Helen J Renaud; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2014-03-20       Impact factor: 4.219

3.  Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis.

Authors:  Shinichiro Yokota; Yoshihiro Ono; Toshimasa Nakao; Peng Zhang; George K Michalopoulos; Zahida Khan
Journal:  J Vis Exp       Date:  2018-03-28       Impact factor: 1.355

4.  RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver.

Authors:  Hao Yin; Roman L Bogorad; Carmen Barnes; Stephen Walsh; Iris Zhuang; Hidenori Nonaka; Vera Ruda; Satya Kuchimanchi; Lubomir Nechev; Akin Akinc; Wen Xue; Marino Zerial; Robert Langer; Daniel G Anderson; Victor Koteliansky
Journal:  J Hepatol       Date:  2015-11-30       Impact factor: 25.083

5.  Bile Acid-Induced Toxicity in HepaRG Cells Recapitulates the Response in Primary Human Hepatocytes.

Authors:  Benjamin L Woolbright; Mitchell R McGill; Huimin Yan; Hartmut Jaeschke
Journal:  Basic Clin Pharmacol Toxicol       Date:  2015-08-13       Impact factor: 4.080

6.  Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis.

Authors:  Benjamin L Woolbright; Kenneth Dorko; Daniel J Antoine; Joanna I Clarke; Parviz Gholami; Feng Li; Sean C Kumer; Timothy M Schmitt; Jameson Forster; Fang Fan; Rosalind E Jenkins; B Kevin Park; Bruno Hagenbuch; Mojtaba Olyaee; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2015-01-28       Impact factor: 4.219

Review 7.  Therapeutic targets for cholestatic liver injury.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Expert Opin Ther Targets       Date:  2015-10-19       Impact factor: 6.902

8.  IL-17A synergistically enhances bile acid-induced inflammation during obstructive cholestasis.

Authors:  Kate M O'Brien; Katryn M Allen; Cheryl E Rockwell; Keara Towery; James P Luyendyk; Bryan L Copple
Journal:  Am J Pathol       Date:  2013-09-05       Impact factor: 4.307

9.  Oxidative Stress and Acute Hepatic Injury.

Authors:  Anup Ramachandran; Hartmut Jaeschke
Journal:  Curr Opin Toxicol       Date:  2018-02

10.  Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice.

Authors:  Benjamin L Woolbright; Daniel J Antoine; Rosalind E Jenkins; Mary Lynn Bajt; B Kevin Park; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2013-10-03       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.